Background: The high-risk ‘suspicious for papillary thyroid carcinoma' (SPTC) is a clinically relevant diagnosis in the cytological interpretation of thyroid aspirates. While The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has provided invaluable terminology standardization, a performance comparison for this diagnostic category has not been performed. Therefore, this study evaluates the SPTC diagnosis before and after the introduction of TBSRTC in a large meta-analysis and at a single institution. Materials and Methods: The meta-analysis analyzed publications of SPTC or similar diagnoses before and after the introduction of TBSRTC. Similarly our own institutional experience was analyzed for the 8 years surrounding the introduction of TBSRTC. A correlation of the cytopathology and surgical pathology diagnoses was performed. Results: The introduction of TBSRTC coincided with a significant decrease in the fraction of cases called SPTC in the meta-analysis (4.5-3.1%, p < 0.00001) and in the institutional review (1.7-0.9%, p = 0.005). Meanwhile, the malignancy risk for those cases increased significantly in the meta-analysis from 62.5 to 80.5% (p < 0.00001) and trended upwards in the institutional review from 69 to 79% (p = 0.4). The follow-up rate was similar in both time periods in the meta-analysis and the institutional review. Conclusions: The introduction of TBSRTC coincided with a decrease in the fraction of cases called SPTC and an increase in the malignancy risk associated with that diagnosis.

1.
Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214.
[PubMed]
2.
Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ: National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009;31:748-758.
[PubMed]
3.
Gharib H, Goellner JR: Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993;118:282-289.
[PubMed]
4.
Olson MT, Clark DP, Erozan YS, Ali SZ: Spectrum of risk of malignancy in subcategories of ‘atypia of undetermined significance'. Acta Cytol 2011;55:518-525.
[PubMed]
5.
Cibas ES, Ali SZ: The Bethesda System for Reporting Thyroid Cytopathology: Thyroid 2009;19:1159-1165.
[PubMed]
6.
Olson MT, Boonyaarunnate T, Aragon Han P, Umbricht CB, Ali SZ, Zeiger MA: A tertiary center's experience with second review of 3,885 thyroid cytopathology specimens. J Clin Endocrinol Metab 201398:1450-1457.
[PubMed]
7.
Ali SZ: Thyroid cytopathology: Bethesda and beyond. Acta Cytol 2011;55:4-12.
[PubMed]
8.
Guidelines of the Papanicolaou Society of Cytopathology for fine-needle aspiration procedure and reporting - the Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol 1997;17:239-247.
[PubMed]
9.
Bongiovanni M, Krane JF, Cibas ES, Faquin WC: The atypical thyroid fine-needle aspiration: past, present, and future. Cancer Cytopathol 2012;120:73-86.
[PubMed]
10.
Renshaw AA: Should ‘atypical follicular cells' in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 2010;118:186-189.
[PubMed]
11.
Theoharis CGA, Schofield KM, Hammers L, Udelsman R, Chhieng DC: The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 2009;19:1215-1223.
[PubMed]
12.
Olson MT, Tatsas AD, Ali SZ: Cytotechnologist attended on-site adequacy evaluation of thyroid fine needle aspiration: comparison with cytopathologists and correlation with the final interpretation. Am J Clin Pathol 2011;138:90-95.
[PubMed]
13.
Lew JI, Snyder RA, Sanchez YM, Solorzano CC: Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg 2011;213:188-194, discussion 194-195.
[PubMed]
14.
Renshaw AA: Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol 2001;116:477-482.
[PubMed]
15.
Seningen JL, Nassar A, Henry MR: Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1,945 cases. Diagn Cytopathol 2012;40(suppl 1):E27-E32.
[PubMed]
16.
Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK: Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007;111:508-516.
[PubMed]
17.
Punthakee X, Palme CE, Franklin JH, Zhang I, Freeman JL, Bedard YC: Fine-needle aspiration biopsy findings suspicious for papillary thyroid carcinoma: a review of cytopathological criteria. Laryngoscope 2005;115:433-436.
[PubMed]
18.
Yang J, Schnadig V, Logrono R, Wasserman PG: Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007;111:306-315.
[PubMed]
19.
Yoder BJ, Redman R, Massoll NA: Validation of a five-tier cytodiagnostic system for thyroid fine needle aspiration biopsies using cytohistologic correlation. Thyroid 2006;16:781-786.
[PubMed]
20.
Goldstein RE, Netterville JL, Burkey B, Johnson JE: Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 2002;235:656-662, discussion 662-664.
[PubMed]
21.
Banks ND, Kowalski J, Tsai H-L, Somervell H, Tufano R, Dackiw APB, Marohn MR, Clark DP, Umbricht CB, Zeiger MA: A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 2008;18:933-941.
[PubMed]
22.
Raj MD, Grodski S, Martin SA, Yeung M, Serpell JW: The role of fine-needle aspiration cytology in the surgical management of thyroid cancer. ANZ J Surg 2010;80:827-830.
[PubMed]
23.
Wu HH, Jones JN, Osman J: Fine-needle aspiration cytology of the thyroid: ten years experience in a community teaching hospital. Diagn Cytopathol 2006;34:93-96.
[PubMed]
24.
Zhang Y, Fraser JL, Wang HH: Morphologic predictors of papillary carcinoma on fine-needle aspiration of thyroid with ThinPrep preparations. Diagn Cytopathol 2001;24:378-383.
[PubMed]
25.
Ravetto C, Colombo L, Dottorini ME: Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma. Cancer 2001;90:357-363.
[PubMed]
26.
Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC: Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid 2011;21:1191.
[PubMed]
27.
Deandrea M, Ragazzoni F, Motta M, Torchio B, Mormile A, Garino F, Magliona G, Gamarra E, Ramunni MJ, Garberoglio R, Limone PP: Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 2010;20:1077-1083.
[PubMed]
28.
Raparia K, Min SK, Mody DR, Anton R, Amrikachi M: Clinical outcomes for ‘suspicious' category in thyroid fine-needle aspiration biopsy: patient's sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med 2009;133:787-790.
[PubMed]
29.
Mastorakis E, Meristoudis C, Margari N, Pouliakis A, Leventakos K, Chroniaris N, Panayiotides I, Karakitsos P: Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation. Cytopathology 2013, DOI: 10.1111/cyt.12062.
[PubMed]
30.
Tepeoğlu M, Bilezikçi B, Bayraktar SG: A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases. Cytopathology 2013, DOI: 10.1111/cyt.12051.
[PubMed]
31.
Ozluk Y, Pehlivan E, Gulluoglu MG, Poyanli A, Salmaslioglu A, Colak N, Kapran Y, Yilmazbayhan D: The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey. Int J Surg Pathol 2011;19:761-771.
[PubMed]
32.
Nayar R, Ivanovic M: The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol 2009;117:195-202.
[PubMed]
33.
Jo VY, Renshaw AA, Krane JF: Relative sensitivity of thyroid fine-needle aspiration by tumor type and size. Diagn Cytopathol 2013, DOI: 10.1002/dc.22976.
[PubMed]
34.
Wu HH, Rose C, Elsheikh TM: The Bethesda system for reporting thyroid cytopathology: an experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol 2012;40:399-403.
[PubMed]
35.
Mathur A, Moses W, Rahbari R, Khanafshar E, Duh Q-Y, Clark O, Kebebew E: Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer 2011;117:4390-4395.
[PubMed]
36.
Kleiman DA, Sporn MJ, Beninato T, Crowley MJ, Nguyen A, Uccelli A, Scognamiglio T, Zarnegar R, Fahey I, Thomas J: Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients. Cancer 2013;119:1495-1502.
[PubMed]
37.
Vandenbussche CJ, Sathiyamoorthy S, Owens CL, Burroughs FH, Rosenthal DL, Guan H: The Johns Hopkins Hospital template for urologic cytology samples. 2, 3. Improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. Cancer Cytopathol 2013;121:21-28.
[PubMed]
You do not currently have access to this content.